rizatriptan has been researched along with Hypomenorrhea in 5 studies
rizatriptan: structure given in first source; RN given refers to benzoate
| Excerpt | Relevance | Reference |
|---|---|---|
| "Frovatriptan was as effective as rizatriptan in the immediate treatment of menstrually related migraine attacks while showing a favorable sustained effect with a lower rate of migraine recurrence." | 2.76 | Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. ( Ferrari, MD; Lisotto, C; Omboni, S; Pinessi, L; Savi, L; Zanchin, G; Zava, D, 2011) |
| "Rizatriptan 10 mg was effective for the treatment of ICHD-II menstrual migraine, as measured by 2-h pain relief and 24-h sustained pain relief." | 2.73 | Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. ( Hustad, CM; Loder, E; Mannix, LK; Mueller, L; Nett, R; Ramsey, KE; Rodgers, A; Skobieranda, F, 2007) |
| "Rizatriptan 10 mg was effective for the treatment of menstrual migraine in an early intervention model, as measured by 2-hour pain freedom." | 2.73 | Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. ( Cady, R; Hustad, CM; Martin, V; Mauskop, A; Ramsey, KE; Rodgers, A; Seidman, LS; Skobieranda, F, 2008) |
| "Rizatriptan 10 mg was superior to placebo for the treatment of PMM, as measured by 2-hour pain relief." | 2.73 | Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. ( Hustad, CM; Mannix, LK; Mueller, L; Nett, R; Ramsey, KE; Rodgers, A; Skobieranda, F, 2008) |
| " In all women, rizatriptan was as effective in treating menstrual as well as nonmenstrual migraine: 68% of 139 patients taking rizatriptan 10 mg with a menstrually associated migraine had pain relief at 2 hours after dosing compared with 69% of 393 patients with nonmenstrually associated attacks (test of menstrual association = nonsignificant; the analysis had 80% power to detect a difference of six percentage points between groups)." | 1.31 | Rizatriptan in the treatment of menstrual migraine. ( Johnson-Pratt, L; Le Jeunne, C; Lines, CR; Massiou, H; McCarroll, KA; Silberstein, SD, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Savi, L | 1 |
| Omboni, S | 1 |
| Lisotto, C | 1 |
| Zanchin, G | 1 |
| Ferrari, MD | 1 |
| Zava, D | 1 |
| Pinessi, L | 1 |
| Mannix, LK | 2 |
| Loder, E | 1 |
| Nett, R | 2 |
| Mueller, L | 2 |
| Rodgers, A | 3 |
| Hustad, CM | 3 |
| Ramsey, KE | 3 |
| Skobieranda, F | 3 |
| Martin, V | 1 |
| Cady, R | 1 |
| Mauskop, A | 1 |
| Seidman, LS | 1 |
| Silberstein, SD | 1 |
| Massiou, H | 1 |
| Le Jeunne, C | 1 |
| Johnson-Pratt, L | 1 |
| McCarroll, KA | 1 |
| Lines, CR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine[NCT00111722] | Phase 3 | 393 participants (Actual) | Interventional | 2005-05-27 | Completed | ||
| A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg Tablets for the Treatment of Menstrual Migraine[NCT00111709] | Phase 3 | 393 participants (Actual) | Interventional | 2005-05-27 | Completed | ||
| A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild[NCT00095004] | Phase 3 | 167 participants (Actual) | Interventional | 2004-10-21 | Completed | ||
| A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild[NCT00092963] | Phase 3 | 529 participants (Actual) | Interventional | 2004-08-17 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for rizatriptan and Hypomenorrhea
| Article | Year |
|---|---|
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
Topics: Acute Disease; Adolescent; Adult; Aged; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; | 2011 |
Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
Topics: Acute Disease; Adolescent; Adult; Analgesics; Comorbidity; Double-Blind Method; Female; Humans; Mens | 2007 |
Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
Topics: Acute Disease; Adolescent; Adult; Analgesics; Comorbidity; Double-Blind Method; Female; Humans; Mens | 2007 |
Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
Topics: Acute Disease; Adolescent; Adult; Analgesics; Comorbidity; Double-Blind Method; Female; Humans; Mens | 2007 |
Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
Topics: Acute Disease; Adolescent; Adult; Analgesics; Comorbidity; Double-Blind Method; Female; Humans; Mens | 2007 |
Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
Topics: Adult; Disability Evaluation; Double-Blind Method; Drug Evaluation; Female; Humans; Menstruation Dis | 2008 |
Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
Topics: Adult; Disability Evaluation; Double-Blind Method; Drug Evaluation; Female; Humans; Menstruation Dis | 2008 |
Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
Topics: Adult; Disability Evaluation; Double-Blind Method; Drug Evaluation; Female; Humans; Menstruation Dis | 2008 |
Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
Topics: Adult; Disability Evaluation; Double-Blind Method; Drug Evaluation; Female; Humans; Menstruation Dis | 2008 |
Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
Topics: Adolescent; Adult; Clinical Protocols; Disability Evaluation; Double-Blind Method; Female; Humans; M | 2008 |
Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
Topics: Adolescent; Adult; Clinical Protocols; Disability Evaluation; Double-Blind Method; Female; Humans; M | 2008 |
Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
Topics: Adolescent; Adult; Clinical Protocols; Disability Evaluation; Double-Blind Method; Female; Humans; M | 2008 |
Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
Topics: Adolescent; Adult; Clinical Protocols; Disability Evaluation; Double-Blind Method; Female; Humans; M | 2008 |
1 other study available for rizatriptan and Hypomenorrhea
| Article | Year |
|---|---|
Rizatriptan in the treatment of menstrual migraine.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Menstrua | 2000 |